A top of 1494 confirmed and 5010 possible cases/week was reached in March 23–29th, 2020, with a maximum of 119 confirmed cases/day on March 25th, 2020. We considered that day to be the peak of the epidemic wave. The pcHRRS started on March 26th, 2020 and has been active since then. From March 26th to April 17th, 2020, 418 and 431 respiratory infection patients were seen through the pcHRRS and the ED, respectively. Ten scheduled patients did not attend the pcHRRS appointment. Those 418 patients accounted for 9.86% of the active confirmed or possible accumulated cases (233 and 4004 patients, respectively) followed-up by telephone in that period of time, and 0.16% of our health area population (265.842 people).
The distribution of pcHRRS patients was: G1 325/418 (77.75%) and G2 93/418 (22.24%) patients (Supplementary fig.5). One patient with known fibrotic pulmonary lesions and other with a calcified granuloma where sent back home and included in G1. One patient refused the ED assessment. Among ED patients (G3), 224/431 (52%), 203/431 (47.10%) and 4/431 (0.93%) returned home, were admitted, or refused admission, respectively. Eight pcHRRS patients encouraged to go home asked for ED assessment before being finally discharged. All them went out from G1 (n = 317; 325 - 8) to be included in G3 (n = 439; 431 + 8) for the efficiency analysis; one G2 patient and four G3 patients refused medical attention and were excluded (Supplementary fig.5).
After starting the pcHRRS, the number of patients/day in the ED gradually decreased (fig.2). G1 patients (0:41 ± 1:05h) stayed in hospital significantly less time than G2 and G3 subjects (5:25 ± 3:08h and 5:36 ± 4:36h, respectively; P <0.001; fig.3), even when G2 and G3 patients returned home (3:36 ± 2:58h and 3:50 ± 3:16h, respectively; P <0.001; fig. 4).The time span in the ED did not differ between G2 and G3 when they returned home (3:36 ± 2:58h vs. 3:50 ± 3:16h; P = 0.841), but was significantly shorter for G2 when patients were admitted (5:27 ± 3:08h vs. 7:42 ± 5:02h; P < 0.001; fig. 4). Even considering pcHRRS and ED times together in G2, patients waited less time than G3 patients, except for the 9/93 (9.6%) G2 patients returning home (4:44 vs 3:50h; fig.4). The pcHRRS had a high yield for admission decisions considering that G2 patients were admitted (84/93, 90.3%) more frequently than G3 (203/431, 47.1%; P <0.001), with a rate per day always higher for G2 (mean rates: 0.92, range 0.67–1 vs. 0.48, range 0.18–0.75), regardless the epidemics time point (fig.5).
All 418 pcHRRS patients underwent posteroanterior and lateral thorax radiographs. Oximetry was implemented on March 31st, being applied systematically from patient 109. After getting empirically good results in four patients, 3DDT was systematically performed since April 1st, starting with patient 152. When we began to write this manuscript, we had all radiological and laboratory data records for the first 212 consecutive patients, all with conventional thorax radiographs and 73 with additional 3DDT. Their mean age was 46.75 ± 13.93 years, 87 (41%) men. Forty-eight (22.64%), 148 (69.81%) and 16 (7.54%) had abnormal, normal and questionable radiographs, respectively. All 48 patients with abnormal radiographs were referred to the ED, as well as 2 patients with normal radiographs and 4 patients with questionable radiographs in whom 3DDT brought out signs of pneumonia (6/54, 11.1%). These 54 patients (G2) were older (50.46 ± 15.73 years) than G1 patients (45.41 ± 13.01 years; P = 0.019), men showing a trend to be more frequently referred to the ED than women (29/87, 33.33% vs. 27/115, 23.48%; P = 0.057) due to radiological abnormalities.
Among those first consecutive 212 patients, a follow-up chest radiograph was requested in 61 cases. That request was less frequent when initial radiographs were normal than when abnormal or questionable (18/148, 12.2% vs. 38/48, 75% vs. 5/16, 31.2%; P <0.001). On the other hand, though follow-up radiographs worsen, respectively, in 15/48 (31.2%) and 2/16 (12.5%) patients with initial abnormal or questionable exams, no initial normal radiograph did it (0/148, 0%) (P <0.001).
SARS-CoV–2 infection was confirmed by reverse transcription polymerase chain reaction (PT-PCR), serology, or both in 37/212 (17.45%) and ruled out in 77/212 patients. In 87/212 patients the infection was ruled out, though results are now under review. We have no data to date on 11/212 patients.
Oximetry was performed in 107/212 patients; in 6/212 data were missing. Mean blood oxygen saturation was lower in patients with abnormal (97.24 ± 1.52%, n = 17 vs. 98.49 ± 0.88 %, n = 75; P <0.001) or questionable radiograph (98.27± 0.80 %, n = 15; P <0.013).